Works about CYTOCHROME P-450 CYP2D6

Results: 515
    1
    2
    3

    Effect of CYP1A2 , CYP2D6 , and CYP3A4 Variation on Antipsychotic Treatment Outcomes.

    Published in:
    Pharmaceuticals (14248247), 2025, v. 18, n. 6, p. 892, doi. 10.3390/ph18060892
    By:
    • Varney, Lauren;
    • Murtough, Stephen;
    • Cotic, Marius;
    • Abidoph, Rosemary;
    • Chan, Lian;
    • Saadullah Khani, Noushin;
    • Richards-Belle, Alvin;
    • Richards-Brown, Maria;
    • Mills, Daisy;
    • Panconesi, Daniele;
    • Dawda, Yogita;
    • Sharma, Parveen;
    • Shah, Chetan;
    • Secchi, Agostina;
    • Nilforooshan, Ramin;
    • Mudholkar, Santosh;
    • Murdoch, Rosie;
    • Molai, Jazmin;
    • Griffiths, Rebecca;
    • Senthilkumar, Suruthy
    Publication type:
    Article
    4
    5
    6
    7

    金鸡菊苷与 CYP3A4/CYP2D6 的 结合特性和稳定性.

    Published in:
    Journal of Jilin University (Science Edition) / Jilin Daxue Xuebao (Lixue Ban), 2024, v. 62, n. 6, p. 1491, doi. 10.13413/j.cnki.jdxblxb.2024185
    By:
    • 李 丽;
    • 李 媛;
    • 陶彦舟;
    • 廉 笛;
    • 崔晶晶;
    • 杜雨桐
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Case report: recurrence of Plasmodium vivax malaria due to defective cytochrome P450 2D6 function in Pos Lenjang, Pahang, Malaysia.

    Published in:
    Transactions of the Royal Society of Tropical Medicine & Hygiene, 2020, v. 114, n. 9, p. 700, doi. 10.1093/trstmh/traa042
    By:
    • Salleh, Noor Hafizan Mat;
    • Rahman, Mohd Faizal Abdul;
    • Samsusah, Samsiah;
    • Silva, Jeremy Ryan De;
    • Ng, David Chun-Ern;
    • Ghozali, Azilawati Hanim;
    • Tan, Jia Hui;
    • Lai, Meng Yee;
    • Amir, Amirah;
    • Liew, Jonathan Wee Kent;
    • Lau, Yee Ling
    Publication type:
    Article
    36
    37

    Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into Account.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 218, doi. 10.1002/cpt.3680
    By:
    • Johansson, Inger;
    • Xanthopoulou, Emmanouella M.;
    • Zhou, Yitian;
    • Sanchez‐Spitman, Anabel;
    • van der Lee, Maaike;
    • Wollmann, Birgit M.;
    • Størset, Elisabet;
    • Swen, Jesse J.;
    • Guchelaar, Henk‐Jan;
    • Molden, Espen;
    • Jukic, Marin M.;
    • Ingelman‐Sundberg, Magnus
    Publication type:
    Article
    38

    Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1‐Year Longitudinal Study.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 263, doi. 10.1002/cpt.3691
    By:
    • Piras, Marianna;
    • Ranjbar, Setareh;
    • Crettol, Séverine;
    • Vandenberghe, Frederik;
    • Ansermot, Nicolas;
    • Grandjean, Carole;
    • Pistis, Giorgio;
    • Preisig, Martin;
    • Curtis, Logos;
    • Gamma, Franziska;
    • Delessert, Didier;
    • Elowe, Julien;
    • Plessen, Kerstin Jessica;
    • von Gunten, Armin;
    • Conus, Philippe;
    • Eap, Chin Bin
    Publication type:
    Article
    39

    A Comprehensive CYP2D6 Drug–Drug–Gene Interaction Network for Application in Precision Dosing and Drug Development.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1718, doi. 10.1002/cpt.3604
    By:
    • Rüdesheim, Simeon;
    • Loer, Helena Leonie Hanae;
    • Feick, Denise;
    • Marok, Fatima Zahra;
    • Fuhr, Laura Maria;
    • Selzer, Dominik;
    • Teutonico, Donato;
    • Schneider, Annika R. P.;
    • Solodenko, Juri;
    • Frechen, Sebastian;
    • van der Lee, Maaike;
    • Moes, Dirk Jan A. R.;
    • Swen, Jesse J.;
    • Schwab, Matthias;
    • Lehr, Thorsten
    Publication type:
    Article
    40
    41
    42

    Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 939, doi. 10.1002/cpt.3351
    By:
    • Duarte, Julio D.;
    • Thomas, Cameron D.;
    • Lee, Craig R.;
    • Huddart, Rachel;
    • Agundez, Jose A. G.;
    • Baye, Jordan F.;
    • Gaedigk, Andrea;
    • Klein, Teri E.;
    • Lanfear, David E.;
    • Monte, Andrew A.;
    • Nagy, Mohamed;
    • Schwab, Matthias;
    • Stein, C. Michael;
    • Uppugunduri, Chakradhara Rao S.;
    • van Schaik, Ron H. N.;
    • Donnelly, Roseann S.;
    • Caudle, Kelly E.;
    • Luzum, Jasmine A.
    Publication type:
    Article
    43
    44
    45

    Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 690, doi. 10.1002/cpt.3238
    By:
    • Mc Laughlin, Anna M.;
    • Helland, Thomas;
    • Klima, Fenja;
    • Koolen, Stijn L.W.;
    • van Schaik, Ron H.N.;
    • Mathijssen, Ron H.J.;
    • Neven, Patrick;
    • Swen, Jesse J.;
    • Guchelaar, Henk‐Jan;
    • Dalenc, Florence;
    • White‐Koning, Melanie;
    • Michelet, Robin;
    • Mikus, Gerd;
    • Schroth, Werner;
    • Mürdter, Thomas;
    • Brauch, Hiltrud;
    • Schwab, Matthias;
    • Søiland, Håvard;
    • Mellgren, Gunnar;
    • Thomas, Fabienne
    Publication type:
    Article
    46
    47
    48
    49
    50